CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- 4 Exercise or conversion Chief Medical Officer acquired 13,333 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
- 4 Planned sale Chief Medical Officer sold 10,000 shares at $25.00 ($250,000)
- 4 Open-market sale Chief Financial Officer sold 2,203 shares at $16.85 ($37,121)
- 4 Open-market sale Chief Medical Officer sold 871 shares at $19.11 ($16,645)
- 4 Open-market sale General Counsel sold 1,520 shares at $19.11 ($29,047)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at $17.69 ($176,900)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale General Counsel sold 7,522 shares at $19.14 ($143,971)
Page 2 of 12 · 233 filings